Efficacy of an oral supplement containing hyaluronic acid, collagen, glucosamine sulfate, chondroitin sulfate, alpha-lipoic acid, methylsulfonylmethane and vitamins on vaginal dryness in young women

Abstract

This study evaluated the oral administration of a new supplement containing a combination of bioactive agents (hyaluronic acid, glucosamine sulfate, chondroitin sulfate, alpha-lipoic acid, methylsulfonylmethane and vitamins A, C and E). The objective of the study was to demonstrate that the oral administration of this product combats vulvovaginal atrophy in young women. This observational study recruited 32 women of fertile age with vaginal dryness, post-coital cystitis and/or dyspareunia (painful intercourse). Patients were evaluated using the VHI scale and the FSFI at baseline and at each follow-up. All patients took one tablet of the supplement twice daily (morning and evening) for two months. After two months, 28 patients (87%) showed an improvement in symptoms and reported complete remission. At the first follow-up at three months, that is, one month after stopping treatment, no substantial changes were reported. At the second follow-up at four months, that is, two months after stopping treatment, vaginal dryness had recurred, and patients were asked to re-start the therapy. We can conclude that this product is highly effective in young women suffering from vaginal dryness and sexual dysfunction caused by oxidative stress.